INMUNE BIO INC Share Price Today: Live Updates & Key Insights

INMUNE BIO INC share price today is $1.2, up -4.1%. The stock opened at $1.27 against the previous close of $1.22, with an intraday high of $1.27 and low of $1.16.

INMUNE BIO INC Share Price Chart

INMUNE BIO INC

us-stock
To Invest in {{usstockname}}
us-stock

INMUNE BIO INC Share Price Performance

$1.2 -0.041(-4.1%) INMB at 23 Mar 2026 01:40 PM Biotechnology
Lowest Today 1.16
Highest Today 1.27
Today’s Open 1.27
Prev. Close 1.22
52 Week High 8.94
52 Week Low 1.16
Day’s Range: Low 1.16 High 1.27
52-Week Range: Low 1.16 High 8.94
1 day return -
1 Week return -13.23
1 month return -7.08
3 month return -37.06
6 month return -40.55
1 year return -85.74
3 year return -82.14
5 year return -91.86
10 year return -

INMUNE BIO INC Institutional Holdings

BlackRock Inc 4.46

Vanguard Group Inc 3.60

Vanguard Total Stock Mkt Idx Inv 1.84

Geode Capital Management, LLC 1.66

iShares Russell 2000 ETF 1.55

Dauntless Investment Group, LLC 1.15

State Street Corp 1.07

Susquehanna International Group, LLP 0.94

Fidelity Small Cap Index 0.77

iShares Russell 2000 Growth ETF 0.77

Vanguard Institutional Extnd Mkt Idx Tr 0.74

Northern Trust Corp 0.71

UBS Group AG 0.59

JPMorgan Chase & Co 0.43

Westside Investment Management, Inc. 0.41

Fidelity Extended Market Index 0.38

Vanguard Russell 2000 ETF 0.36

Morgan Stanley - Brokerage Accounts 0.28

SSgA Russell Small Cap Completeness Idx 0.24

State St Russell Sm/Mid Cp® Indx SL Cl I 0.24

Deutsche Bank AG 0.23

Bank of New York Mellon Corp 0.23

iShares Micro-Cap ETF 0.22

Charles Schwab Investment Management Inc 0.19

Schwab Small Cap Index 0.19

NT R2000 Index Fund - NL 0.18

XTX Topco Ltd 0.18

Blackrock Extended Mkt Fund CF 0.17

Jain Global LLC 0.16

State St Russell Sm Cap® Indx SL Cl I 0.16

Buckingham Strategic Partners 0.15

NT R2000 Index Fund - DC - NL - 3 0.15

Extended Equity Market Fund K 0.14

PNC Financial Services Group Inc 0.14

Stt Strt SPDR® Russell2000 US SmCapETF 0.14

Russell 2500™ Index Fund F 0.13

Barclays PLC 0.11

Fidelity Total Market Index 0.11

Wolverine Trading LLC 0.11

iShares Russell 2000 Small-Cap Idx Instl 0.09

INMUNE BIO INC Market Status

Strong Buy: 2

Buy: 3

Hold: 0

Sell: 0

Strong Sell: 0

INMUNE BIO INC Fundamentals

Market Cap 31.10 M

PB Ratio 1.2361

PE Ratio 0.0

Enterprise Value 4.72 M

Total Assets 39.56 M

Volume 2504285

INMUNE BIO INC Company Financials

Annual Revenue FY23:224000 0.2M, FY22:374000 0.4M, FY21:181000 0.2M, FY20:10916 0.0M, FY19:77688000 77.7M

Annual Profit FY23:null 0.0M, FY22:374000 0.4M, FY21:181000 0.2M, FY20:10916 0.0M, FY19:77688000 77.7M

Annual Net worth FY23:-27433000 -27.4M, FY22:-28647000 -28.6M, FY21:-30340000 -30.3M, FY20:-12099159 -12.1M, FY19:-9142625 -9.1M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:50000 0.1M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-28000 -0.0M, Q2/2025:null 0.0M, Q1/2025:50000 0.1M, Q3/2024:null 0.0M, Q2/2024:null 0.0M

Quarterly Net worth Q3/2025:-6472000 -6.5M, Q2/2025:-24458000 -24.5M, Q1/2025:-9739000 -9.7M, Q3/2024:-12093000 -12.1M, Q2/2024:-9746000 -9.7M

About INMUNE BIO INC & investment objective

Company Information INmune Bio Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. The company's development programs include INKmune, which is in Phase 1 for the treatment of patients with high-risk myelodysplastic syndrome; and INB03, which is in Phase II for the treatment of breast cancer. It provides XPro1595 for the treatment of Alzheimer's disease and treatment resistant depression; and CORDstrom, a cell suspension for intravenous infusion or injection comprising aseptic, allogeneic, and pooled HucMSCs. It has license agreements with Xencor, Inc.; Immune Ventures, LLC; and University of Pittsburg. INmune Bio Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida.

Organisation Biotechnology

Employees 13

Industry Biotechnology

CEO Mr. David J. Moss M.B.A.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

INMUNE BIO INC FAQs

What is the share price of INMUNE BIO INC today?

The current share price of INMUNE BIO INC is $1.2.

Can I buy INMUNE BIO INC shares in India?

Yes, Indian investors can buy INMUNE BIO INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy INMUNE BIO INC shares in India?

You can easily invest in INMUNE BIO INC shares from India by:

Can I buy fractional shares of INMUNE BIO INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of INMUNE BIO INC?

INMUNE BIO INC has a market cap of $31.10 M.

In which sector does INMUNE BIO INC belong?

INMUNE BIO INC operates in the Biotechnology sector.

What documents are required to invest in INMUNE BIO INC stocks?

To invest, you typically need:

What is the PE and PB ratio of INMUNE BIO INC?

The PE ratio of INMUNE BIO INC is N/A and the PB ratio is 1.24.